|
1
|
Ried K, Toben C and Fakler P: Effect of
garlic on serum lipids: An updated meta-analysis. Nutr Rev.
71:282–299. 2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Tosheska Trajkovska K and Topuzovska S:
High-density lipoprotein metabolism and reverse cholesterol
transport: Strategies for raising HDL cholesterol. Anatol J
Cardiol. 18:149–154. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hassing HC, Surendran RP, Derudas B,
Verrijken A, Francque SM, Mooij HL, Bernelot Moens SJ, Hart LM,
Nijpels G, Dekker JM, et al: SULF2 strongly prediposes to fasting
and postprandial triglycerides in patients with obesity and type 2
diabetes mellitus. Obesity (Silver Spring). 22:1309–1316.
2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Walther TC and Farese RV Jr: Lipid
droplets and cellular lipid metabolism. Annu Rev Biochem.
81:687–714. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Endo H, Shiroki T, Nakagawa T, Yokoyama M,
Tamai K, Yamanami H, Fujiya T, Sato I, Yamaguchi K, Tanaka N, et
al: Enhanced expression of long non-coding RNA HOTAIR is associated
with the development of gastric cancer. PLoS One.
8(e77070)2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hirose T, Mishima Y and Tomari Y: Elements
and machinery of non-coding RNAs: Toward their taxonomy. EMBO Rep.
15:489–507. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lee JT: Epigenetic regulation by long
noncoding RNAs. Science. 338:1435–1439. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhang Y, Sun L, Xuan L, Pan Z, Hu X, Liu
H, Bai Y, Jiao L, Li Z, Cui L, et al: Long non-coding RNA CCRR
controls cardiac conduction via regulating intercellular coupling.
Nat Commun. 9(4176)2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Uchida S and Dimmeler S: Long noncoding
RNAs in cardiovascular diseases. Circ Res. 116:737–750.
2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chen J, Cui X, Shi C, Chen L, Yang L, Pang
L, Zhang J, Guo X, Wang J and Ji C: Differential lncRNA expression
profiles in brown and white adipose tissues. Mol Genet Genomics.
290:699–707. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Smekalova EM, Kotelevtsev YV, Leboeuf D,
Shcherbinina EY, Fefilova AS, Zatsepin TS and Koteliansky V: lncRNA
in the liver: Prospects for fundamental research and therapy by RNA
interference. Biochimie. 131:159–172. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Han P, Li W, Lin CH, Yang J, Shang C,
Nuernberg ST, Jin KK, Xu W, Lin CY, Lin CJ, et al: A long noncoding
RNA protects the heart from pathological hypertrophy. Nature.
514:102–106. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Guo W, Zhang H, Yang A, Ma P, Sun L, Deng
M, Mao C, Xiong J, Sun J, Wang N, et al: Homocysteine accelerates
atherosclerosis by inhibiting scavenger receptor class B member1
via DNMT3b/SP1 pathway. J Mol Cell Cardiol. 138:34–48.
2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Leary S, Underwood W and Anthony R: AVMA
Guidelines for the Euthanasia of Animals: 2013 Edition. 2013.
American Veterinary Medical Association. Available from: avma.org/sites/default/files/2020-01/2020-Euthanasia-Final-1-17-20.pdf.
|
|
15
|
Ozay R, Uzar E, Aktas A, Uyar ME, Gürer B,
Evliyaoglu O, Cetinalp NE and Turkay C: The role of oxidative
stress and inflammatory response in high-fat diet induced
peripheral neuropathy. J Chem Neuroanat. 55:51–57. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Owens AP III, Byrnes JR and Mackman N:
Hyperlipidemia, tissue factor, coagulation, and simvastatin. Trends
Cardiovasc Med. 24:95–98. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Liu TT, Zeng Y, Tang K, Chen X, Zhang W
and Xu XL: Dihydromyricetin ameliorates atherosclerosis in LDL
receptor deficient mice. Atherosclerosis. 262:39–50.
2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Xenoulis PG and Steiner JM: Lipid
metabolism and hyperlipidemia in dogs. Vet J. 183:12–21.
2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lee YJ, Seo JA, Yoon T, Seo I, Lee JH, Im
D, Lee JH, Bahn KN, Ham HS, Jeong SA, et al: Effects of low-fat
milk consumption on metabolic and atherogenic biomarkers in Korean
adults with the metabolic syndrome: A randomised controlled trial.
J Hum Nutr Diet. 29:477–486. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Singhai A, Wakefield DL, Bryant KL, Hammes
SR, Holowka D and Baird B: Spatially defined EGF receptor
activation reveals an F-actin-dependent phospho-Erk signaling
complex. Biophys J. 107:2639–2651. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zaczek A, Brandt B and Bielawski KP: The
diverse signaling network of EGFR, HER2, HER3 and HER4 tyrosine
kinase receptors and the consequences for therapeutic approaches.
Histol Histopathol. 20:1005–1015. 2005.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Coulthard LG, Hawksworth OA and Woodruff
TM: Complement: The emerging architect of the developing brain.
Trends Neurosci. 41:373–384. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Matsumoto H, Kanemitsu Y, Nagasaki T,
Tohda Y, Horiguchi T, Kita H, Kuwabara K, Tomii K, Otsuka K,
Fujimura M, et al: Staphylococcus aureus enterotoxin sensitization
involvement and its association with the CysLTR1 variant in
different asthma phenotypes. Ann Allergy Asthma Immunol.
118:197–203. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kowarik MC, Cepok S, Sellner J, Grummel V,
Weber MS, Korn T, Berthele A and Hemmer B: CXCL13 is the major
determinant for B cell recruitment to the CSF during
neuroinflammation. J Neuroinflammation. 9(93)2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Askmyr M, Ågerstam H, Hansen N, Gordon S,
Arvanitakis A, Rissler M, Juliusson G, Richter J, Järås M and
Fioretos T: Selective killing of candidate AML stem cells by
antibody targeting of IL1RAP. Blood. 121:3709–3713. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Hu C, Yang J, He Q, Luo Y, Chen Z, Yang L,
Yi H, Li H, Xia H, Ran D, et al: CysLTR1 blockage ameliorates liver
injury caused by aluminum-overload via PI3K/AKT/mTOR-mediated
autophagy activation in vivo and in vitro. Mol Pharm. 15:1996–2006.
2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kistler B, Schlegel A, Grauert M, Arndt K
and Williams C: Cell type specific accessibility of C5aR2 on human
blood cells of myeloid origin. Eur Resp J. 48(PA3637)2016.
|
|
28
|
Pundir P, MacDonald CA and Kulka M: The
novel receptor C5aR2 is required for C5a-mediated human mast cell
adhesion, migration, and proinflammatory mediator production. J
Immunol. 195:2774–2787. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
La X, Zhang L, Li H, Li Z, Song G, Yang P
and Yang Y: Ajuba receptor mediates the internalization of
tumor-secreted GRP78 into macrophages through different endocytosis
pathways. Oncotarget. 9:15464–15479. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Li Q, Peng H, Fan H, Zou X, Liu Q, Zhang
Y, Xu H, Chu Y, Wang C, Ayyanathan K, et al: The LIM protein Ajuba
promotes adipogenesis by enhancing PPARγ and p300/CBP interaction.
Cell Death Differ. 23:158–168. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Liu QY, Quinet E and Nambi P: Adipocyte
fatty acid-binding protein (aP2), a newly identified LXR target
gene, is induced by LXR agonists in human THP-1 cells. Mol Cell
Biochem. 302:203–213. 2007.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Beaudry JB, Pierreux CE, Hayhurst GP,
Plumb-Rudewiez N, Weiss MC, Rousseau GG and Lemaigre FP: Threshold
levels of hepatocyte nuclear factor 6 (HNF-6) acting in synergy
with HNF-4 and PGC-1alpha are required for time-specific gene
expression during liver development. Mol Cell Biol. 26:6037–6046.
2006.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Holterman A, Wang K, Wang M and Gannon M:
Transcriptional regulation of hepatic genes by hepatocyte nuclear
factor OC1 attenuates liver injury. J Surg Res. 158(324)2010.
|
|
34
|
Zadjali F, Santana-Farre R, Vesterlund M,
Carow B, Mirecki-Garrido M, Hernandez-Hernandez I,
Flodström-Tullberg M, Parini P, Rottenberg M, Norstedt G, et al:
SOCS2 deletion protects against hepatic steatosis but worsens
insulin resistance in high-fat-diet-fed mice. FASEB J.
26:3282–3291. 2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Leroith D and Nissley P: Knock your SOCS
off! J Clin Invest. 115:233–236. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
36
|
Vesterlund M: The mechanism of action of
SOCS2 and its role in metabolism and growth. Arthritis Rheum.
60:1743–1752. 2013.
|
|
37
|
Terrell AM, Crisostomo PR, Wairiuko GM,
Wang M, Morrell ED and Meldrum DR: Jak/STAT/SOCS signaling circuits
and associated cytokine-mediated inflammation and hypertrophy in
the heart. Shock. 26:226–234. 2006.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Komposch K and Sibilia M: EGFR signaling
in liver diseases. Int J Mol Sci. 17(30)2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Scheving LA, Zhang X, Garcia OA, Wang RF,
Stevenson MC, Threadgill DW and Russell WE: Epidermal growth factor
receptor plays a role in the regulation of liver and plasma lipid
levels in adult male mice. Am J Physiol Gastrointest Liver Physiol.
306:G370–G381. 2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Leedman P, Giles K and Webster RJ: Method
of modulation of expression of epidermal growth factor receptor
(EGFR) involving miRNA. Patent application EP, US86738722014. Filed
28 August 2007; issued 6 March, 2008.
|
|
41
|
Deshmukh HA, Colhoun HM, Johnson T,
McKeigue PM, Betteridge DJ, Durrington PN, Fuller JH, Livingstone
S, Charlton-Menys V, Neil A, et al: Genome-wide association study
of genetic determinants of LDL-c response to atorvastatin therapy:
Importance of Lp(a). J Lipid Res. 53:1000–1011. 2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Yamamoto K, Matsuoka T, Kawashima S,
Takebe S, Kubo F, Miyatsuka T, et al: A novel function of Onecut1
as a negative regulator of MafA. J Biol Chem. 288:21648–21658.
2013.PubMed/NCBI View Article : Google Scholar
|
